1. Home
  2. ASPI vs CMPX Comparison

ASPI vs CMPX Comparison

Compare ASPI & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ASP Isotopes Inc.

ASPI

ASP Isotopes Inc.

N/A

Current Price

$4.28

Market Cap

475.3M

Sector

Industrials

ML Signal

N/A

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

N/A

Current Price

$2.28

Market Cap

408.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASPI
CMPX
Founded
2021
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
475.3M
408.8M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
ASPI
CMPX
Price
$4.28
$2.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
$12.00
$14.57
AVG Volume (30 Days)
3.9M
3.1M
Earning Date
04-10-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$23,849,000.00
N/A
Revenue This Year
$68.41
N/A
Revenue Next Year
$126.69
$934.41
P/E Ratio
N/A
N/A
Revenue Growth
475.48
N/A
52 Week Low
$3.51
$1.61
52 Week High
$14.49
$6.88

Technical Indicators

Market Signals
Indicator
ASPI
CMPX
Relative Strength Index (RSI) 47.35 59.56
Support Level $3.98 $1.82
Resistance Level $5.88 $2.47
Average True Range (ATR) 0.28 0.13
MACD 0.12 0.04
Stochastic Oscillator 85.79 80.37

Price Performance

Historical Comparison
ASPI
CMPX

About ASPI ASP Isotopes Inc.

ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Currently, the company has three operating segments: (i) nuclear fuels, (ii) specialist isotopes and related services, and (iii) construction services. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: